| Bioactivity | HER2/neu (654-662) GP2 is a nine amino acid peptide derived from the human epidermal growth factor receptor 2 (HER2/nue, 654–662), induces HLA-A2-restricted cytotoxic T lymphocytes (CTL) reactive to various epithelial cancers[1][2]. | ||||||
| Name | HER2/neu (654-662) GP2 | ||||||
| CAS | 160790-21-6 | ||||||
| Sequence | Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu | ||||||
| Shortening | IISAVVGIL | ||||||
| Formula | C42H77N9O11 | ||||||
| Molar Mass | 884.11 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
HER2/neu (654-662) GP2
CAS: 160790-21-6 F: C42H77N9O11 W: 884.11
HER2/neu (654-662) GP2 is a nine amino acid peptide derived from the human epidermal growth factor receptor 2 (HER2/nue,
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.